Arthritic Therapeutic Market Growth Through 2030 Creates New Strategic Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Arthritic Therapeutic Market Expected To Reach $97.09 Billion By 2030 At 6% CAGR
The market for arthritis therapeutics has experienced solid expansion in recent years, with projections indicating an increase from $72.44 billion in 2025 to $77 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.3%. This growth is driven by several factors, including a rising global prevalence of arthritis, a growing elderly population, restricted availability of advanced treatment options, heightened awareness regarding arthritis management, and the expansion of hospital and clinic facilities.
The size of the arthritic therapeutic market is anticipated to experience robust expansion over the coming years. By 2030, it is projected to reach $97.09 billion, reflecting a compound annual growth rate (CAGR) of 6.0%. This forecast period growth is driven by the development of novel biologics and targeted therapies, a growing reliance on telemedicine and remote patient monitoring, the incorporation of digital health platforms, heightened funding for arthritis research and clinical trials, and the advancement of personalized medicine strategies for arthritis treatment. Key trends shaping this period include the widespread use of biologic and targeted therapies for managing arthritis, a shift toward customized arthritis care plans, an uptick in home-based physical therapy and rehabilitation options, the growth of online pharmacies and digital distribution channels, and a heightened emphasis on early detection and preventive arthritis management.
Download A Free Sample Report For Comprehensive Market Insights:
Arthritic Therapeutic Market Development Factors: Which Trends Are Supporting Demand?
The rising prevalence of arthritis is anticipated to drive expansion in the arthritic therapeutic market moving forward. Arthritis encompasses over 100 conditions primarily marked by joint pain and inflammation. Its incidence is climbing due to an aging population, higher obesity rates, and lifestyle factors that exacerbate joint stress and inflammation. Therapeutic approaches for arthritis work to ease symptoms, curb inflammation, and enhance joint function, thereby improving the quality of life for individuals affected. As an example, a report published in June 2024 by the Australian Institute of Health and Welfare, an Australian government entity, indicated that roughly 514,000 people (2.0% of the population) had rheumatoid arthritis in 2022. In 2023, rheumatoid arthritis accounted for 2.0% of the total disease burden and represented 16% of the overall burden from all musculoskeletal conditions. Consequently, the growing incidence of arthritis is fueling growth in the arthritic therapeutic market.
Arthritic Therapeutic Market Categorization By Product Type And Application
The arthritic therapeutic market covered in this report is segmented –
1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors
3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam
4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone
5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat
6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications
Arthritic Therapeutic Market Transformation Trends: Which Innovations Are Driving Change?
Key players in the arthritis therapeutic market are prioritizing the creation of cutting-edge approaches, including biosimilar monoclonal antibody-based therapies, aimed at improving treatment outcomes while lowering costs. These biosimilar therapies are engineered to closely resemble and replicate the action of original monoclonal antibodies, delivering comparable therapeutic advantages at a more affordable price point. A case in point is May 2024, when Bio-Thera Solutions Ltd., a Chinese biopharmaceutical firm, introduced TOFIDENCE, an intravenous biosimilar monoclonal antibody product based on ACTEMRA. Formulated as a biosimilar to the reference drug ACTEMRA, TOFIDENCE (tocilizumab-bavi) has received approval for managing moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and polyarticular juvenile idiopathic arthritis.
Arthritic Therapeutic Market Company Landscape And Strategic Competition
Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH
Access The Complete Arthritic Therapeutic Market Report:
Arthritic Therapeutic Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the arthritic therapeutic market in 2025. The regions covered in the arthritic therapeutic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
